Clinical challenges: Myeloma and concomitant Type 2 Diabetes

Clinical challenges: Myeloma and concomitant Type 2 Diabetes

Show other versions (1)

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wi...

Full description

Bibliographic Details
Main Authors: Yasar Albushra Abdul Rahiem Ahmed, Awad Eltayeb
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2013-03-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Diabetes mellitus
Multiple myeloma
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463
id doaj-aaa830def7394eb6a92c1b141c16abcc
record_format Article
spelling doaj-aaa830def7394eb6a92c1b141c16abcc2020-11-25T04:06:50ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072013-03-0171Clinical challenges: Myeloma and concomitant Type 2 DiabetesYasar Albushra Abdul Rahiem Ahmed0Awad Eltayeb1MRCP MRCPS FRSM, Adult Medical oncology, Princess Noorah oncology Center, King Abdulaziz Medical City, National Guard Health Affairs, Saudia Arabia.Ph.D; FRCP FRCPath, (Haematology), Professor of Hematology, King Khalid University, Abha, Saudi Arabia. Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463Diabetes mellitusMultiple myeloma
collection DOAJ
language English
format Article
sources DOAJ
author Yasar Albushra Abdul Rahiem Ahmed
Awad Eltayeb
spellingShingle Yasar Albushra Abdul Rahiem Ahmed
Awad Eltayeb
Clinical challenges: Myeloma and concomitant Type 2 Diabetes
International Journal of Hematology-Oncology and Stem Cell Research
Diabetes mellitus
Multiple myeloma
author_facet Yasar Albushra Abdul Rahiem Ahmed
Awad Eltayeb
author_sort Yasar Albushra Abdul Rahiem Ahmed
title Clinical challenges: Myeloma and concomitant Type 2 Diabetes
title_short Clinical challenges: Myeloma and concomitant Type 2 Diabetes
title_full Clinical challenges: Myeloma and concomitant Type 2 Diabetes
title_fullStr Clinical challenges: Myeloma and concomitant Type 2 Diabetes
title_full_unstemmed Clinical challenges: Myeloma and concomitant Type 2 Diabetes
title_sort clinical challenges: myeloma and concomitant type 2 diabetes
publisher Tehran University of Medical Sciences
series International Journal of Hematology-Oncology and Stem Cell Research
issn 2008-2207
publishDate 2013-03-01
description Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
topic Diabetes mellitus
Multiple myeloma
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463
work_keys_str_mv AT yasaralbushraabdulrahiemahmed clinicalchallengesmyelomaandconcomitanttype2diabetes
AT awadeltayeb clinicalchallengesmyelomaandconcomitanttype2diabetes
_version_ 1724430554426769408

Similar Items